folic acid has been researched along with Bone Cancer in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 8 (42.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, X; Jing, D; Liu, J; Pu, F; Shao, Z; Wu, W; Xiao, H; Zhang, Z | 1 |
| Chen, L; Chen, YN; Gu, YJ; Qian, HY; Song, Y; Zhang, HL; Zhang, L; Zhou, F | 1 |
| Dong, S; Gao, Q; Gao, Y; He, X; Li, N; Li, X; Wang, S; Wang, Z; Zhang, B | 1 |
| Jia, ML; Liu, SY; Liu, W; Yang, H; Zeng, XF; Zhang, W; Zhu, WT | 1 |
| Chen, W; Kang, Y; Lou, Y; Xu, W | 1 |
| Xie, C; Yang, Y; Zhao, Y; Zhao, Z | 1 |
| Chen, HH; Chen, SH; Chiang, WH; Chiu, HC; Chuang, CL; Liu, TI | 1 |
| Coulembier, O; De Winter, J; Dozio, SM; Liénard, R; Mineo, PG; Montesi, M; Panseri, S; Piperno, A; Scala, A; Vento, F | 1 |
| Huang, LL; Li, D; Pang, JD; Sun, K; Wang, F; Wang, LT; Wang, R; Zhang, LM | 1 |
| Dolžan, V; Goričar, K; Jazbec, J; Kovač, V; Lamovec, J; Zakotnik, B | 1 |
| Gorlick, R; Healey, JH; Hoang, BH; Qin, J; Yang, R | 1 |
| Marrodán, L; Patiño-García, A; San-Julián, M; Sierrasesúmaga, L; Zalacaín, M | 1 |
| Arpin, D; Biron, E; Cadranel, J; Duruisseaux, M; Guérin, JC; Pérol, M | 1 |
| Anastasilakis, AD; Arsos, G; Barmpalios, G; Efstathiadou, Z; Kita, M; Litsas, I; Makrigiannaki, E; Moralidis, E; Panagiotou, A; Papatheodorou, A; Polyzos, SA; Terpos, E; Triantafillidou, E; Zafeiriadou, E | 1 |
| Andersen, AM; Hall, KS; Holmboe, L; Mørkrid, L; Slørdal, L | 1 |
| Bergh, A; Hallmans, G; Hultdin, J; Stattin, P; Van Guelpen, B | 1 |
| Chou, A; Gorlick, R; Healey, JH; Hoang, B; Huvos, AG; Kolb, EA; Meyers, PA; Qin, J; Sowers, R; Yang, R | 1 |
| STOCK, CC; THIERSCH, JB | 1 |
| Janka, G | 1 |
1 trial(s) available for folic acid and Bone Cancer
| Article | Year |
|---|---|
Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid.
Topics: 25-Hydroxyvitamin D 2; Aged; Alkaline Phosphatase; Biomarkers; Body Mass Index; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Calcifediol; Cohort Studies; Collagen Type I; Diphosphonates; Female; Folic Acid; Homocysteine; Humans; Imidazoles; Isoenzymes; Male; Paget Disease, Extramammary; Peptides; Pilot Projects; Time Factors; Vitamin B 12; Zoledronic Acid | 2010 |
18 other study(ies) available for folic acid and Bone Cancer
| Article | Year |
|---|---|
Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1.
Topics: Adolescent; B7-H1 Antigen; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Folic Acid; Humans; Janus Kinase 2; Liposomes; Osteosarcoma; Quercetin; STAT3 Transcription Factor | 2022 |
Folic acid relieves bone cancer pain by downregulating P2X2/3 receptors in rats.
Topics: Analgesics; Animals; Bone Neoplasms; Cancer Pain; Folic Acid; Ganglia, Spinal; Hyperalgesia; Neuralgia; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2023 |
MiRNA-520a-3p combined with folic acid conjugated Fe
Topics: Adolescent; Bone Neoplasms; Cell Line, Tumor; Folic Acid; Humans; Magnetic Resonance Imaging; MicroRNAs; Nanoparticles; Osteosarcoma; Photothermal Therapy | 2023 |
Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Folic Acid; Humans; Janus Kinase 2; Lipopolysaccharides; Liposomes; Lung Neoplasms; Mice; Osteosarcoma; Resveratrol; STAT3 Transcription Factor | 2023 |
Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Metal-Organic Frameworks; Nanoparticles; Osteosarcoma | 2020 |
Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Female; Folic Acid; Glutamic Acid; Humans; Ligands; Liposomes; Oligopeptides; Rats; Wound Healing | 2020 |
Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.
Topics: Alendronate; Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Female; Folic Acid; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2020 |
Design of naturally inspired jellyfish-shaped cyclopolylactides to manage osteosarcoma cancer stem cells fate.
Topics: Bone Neoplasms; Cell Line, Tumor; Folic Acid; Humans; Nanoparticles; Neoplastic Stem Cells; Osteosarcoma; Polyethylene Glycols | 2020 |
Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy.
Topics: Animals; Bone Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Chitosan; Dendrimers; Folic Acid; Gene Silencing; Genetic Therapy; Humans; Male; Matrix Metalloproteinase 2; Membrane Proteins; Mice, Nude; Nanoparticles; Osteosarcoma; Polylysine; RNA-Binding Proteins; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2018 |
Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Female; Folic Acid; Humans; Liver-Specific Organic Anion Transporter 1; Male; Methotrexate; Organic Anion Transporters; Osteosarcoma; Polymorphism, Single Nucleotide; Survival Analysis; Treatment Outcome; Young Adult | 2014 |
Polymorphisms and methylation of the reduced folate carrier in osteosarcoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; DNA Methylation; Female; Folic Acid; Humans; Male; Membrane Transport Proteins; Middle Aged; Osteosarcoma; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Reduced Folate Carrier Protein; RNA, Messenger; Transcription, Genetic | 2008 |
Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Carrier Proteins; Case-Control Studies; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Folate Receptors, GPI-Anchored; Folic Acid; Gastrointestinal Diseases; Genotype; Hematologic Diseases; Humans; Kidney Diseases; Male; Methotrexate; Osteosarcoma; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Cell Surface; RNA, Messenger; Tetrahydrofolate Dehydrogenase | 2009 |
Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Cough; Disease Progression; Dyspnea; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neutropenia; Pemetrexed; Remission Induction; Renal Insufficiency; Smoking; Tomography, X-Ray Computed; Vitamin B 12 | 2009 |
High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients.
Topics: Adolescent; Adult; Age Factors; Antimetabolites, Antineoplastic; Area Under Curve; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Female; Folic Acid; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Reduced Folate Carrier Protein; Sex Factors; Treatment Outcome; Young Adult | 2012 |
Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.
Topics: Adult; Aged; Bone Neoplasms; Case-Control Studies; Folic Acid; Homocysteine; Humans; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Risk Factors; Sweden; Vitamin B 12 | 2005 |
The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Carrier Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Folate Receptors, GPI-Anchored; Folic Acid; Folic Acid Antagonists; Humans; Methotrexate; Osteosarcoma; Receptors, Cell Surface; RNA, Messenger; Tetrahydrofolates; Xenograft Model Antitumor Assays | 2007 |
Bone marrow of mice bearing sarcoma 180 treated with 4-amino-pteroylglutamic acid and with 4-amino-N10-methyl-pteroylglutaminic acid.
Topics: Aminopterin; Animals; Bone and Bones; Bone Marrow; Bone Neoplasms; Folic Acid; Mice; Neoplasms; Sarcoma 180; Sarcoma, Experimental | 1949 |
[Malignant juvenile bone tumors].
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Bone Neoplasms; Child; Diagnosis, Differential; Doxorubicin; Drug Therapy, Combination; Eosinophilic Granuloma; Female; Folic Acid; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Osteomyelitis; Osteosarcoma; Sarcoma, Ewing | 1978 |